Cardiac Rhythm Management
Implantable and external devices that monitor and treat cardiac arrhythmias, pacemakers, ICDs, CRT devices, and insertable cardiac monitors.
Definition
Cardiac Rhythm Management (CRM) is the MedTech segment that develops devices for diagnosing and treating bradyarrhythmias, tachyarrhythmias, and heart failure conduction disorders. The category covers permanent pacemakers (single, dual, leadless), implantable cardioverter defibrillators (ICDs), cardiac resynchronization therapy (CRT-P, CRT-D), insertable cardiac monitors (ICMs), and the leads, programmers, and remote-monitoring infrastructure that surround them. CRM devices are almost exclusively Class III in the US (PMA pathway) because they support or sustain life, and almost all modern CRM systems include wireless telemetry that places them squarely under FDA's Section 524B cyber device authority.What this means in practice
CRM is one of the highest-revenue MedTech segments and a leading source of post-market cybersecurity advisories (Medtronic CareLink/Conexus, St. Jude Merlin@home). Market dynamics are shaped by leadless pacing, extravascular ICDs, conduction-system pacing, and remote-monitoring reimbursement (CPT 93294-93298).Examples
- A patient experiencing chronic bradycardia receives an implantable pulse generator designed to deliver electrical impulses to the heart, ensuring a consistent and appropriate heart rate to alleviate symptoms like dizziness and fatigue.
- Individuals at high risk for life-threatening ventricular arrhythmias may be implanted with a device that continuously monitors heart activity and can deliver a high-energy shock to restore a normal rhythm if a dangerous arrhythmia is detected.
- A heart failure patient undergoes implantation of a specialized device that coordinates the contractions of the heart's ventricles, improving the heart's pumping efficiency and overall cardiac function.
- •Treating CRM telemetry links as a closed system, they are cyber-device interfaces under 524B.
- •Underestimating the regulatory burden of lead changes, which often require a PMA supplement.
- •Ignoring remote-monitoring reimbursement codes that materially shape product economics.
Frequently asked questions
Related terms
Grouped by themeEditor's picks
· Hand-selected related conceptsDiagnosis and catheter-based treatment of cardiac arrhythmias.
Implantable devices that stimulate the nervous system to treat disease.
Transcatheter therapies for valvular and structural heart disease.
FDA's most stringent device marketing application, required for high-risk Class III devices.
More in Market Segments
· Same categoryLasers, RF, ultrasound, cryolipolysis, and IPL systems used for medical and cosmetic indications, body contouring, hair removal, skin tightening, vascular lesions.
Software that analyzes medical images to triage, detect, or quantify disease.
Devices for diagnosing, monitoring, or treating cardiovascular disease.
U.S. federal standards that govern clinical laboratory testing.
Where this term appears across MedTech Terms.
Latest in MedTech
Sources
3 sourcesSources support the definition or relevant regulatory context, not necessarily every claim on this page. Each is graded against our source-tier hierarchy so you can see what rests on binding law versus commentary.
- 1FDA, PacemakersTier 2 VerifiedFDAfda.gov
- 2ISO 14708-2 Active implantable medical devices, PacemakersTier 1 VerifiedISOiso.org
- 3Heart Rhythm Society Remote Monitoring ConsensusTier 4 VerifiedHRShrsonline.org
Inline markers like [1] jump to the matching reference above.